Secukinmab

DRUG2 trials

Sponsors

Novartis Pharmaceuticals

Conditions

Hidradenitis Suppurativa (HS)Rheumatoid Arthritis

Phase 2

Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX)

CompletedNCT00928512

Novartis PharmaceuticalsRheumatoid Arthritis

Start: 2009-07-31End: 2011-03-31Updated: 2015-10-30

Unknown Phase

Short-term Treatment Satisfaction in Hidradenitis Suppurativa Patients Initiated on Cosentyx in Routine Clinical Practice in Saudi Arabia

RecruitingNCT06785779

Novartis PharmaceuticalsHidradenitis Suppurativa (HS)

Start: 2025-03-10End: 2026-09-30Target: 77Updated: 2025-12-30

Related Papers

One-year efficacy and safety results of secukinumab in patients with rheumatoid arthritis: phase II, dose-finding, double-blind, randomized, placebo-controlled study.

2014-01-1577 citations